» Articles » PMID: 33856653

Alteration and Dysfunction of Ion Channels/transporters in a Hypoxic Microenvironment Results in the Development and Progression of Gastric Cancer

Overview
Publisher Springer
Date 2021 Apr 15
PMID 33856653
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gastric cancer (GC) is one of the most common malignant cancers in the world and has only few treatment options and, concomitantly, a poor prognosis. It is generally accepted now that the tumor microenvironment, particularly that under hypoxia, plays an important role in cancer development. Hypoxia can regulate the energy metabolism and malignancy of tumor cells by inducing or altering various important factors, such as oxidative stress, reactive oxygen species (ROS), hypoxia-inducible factors (HIFs), autophagy and acidosis. In addition, altered expression and/or dysfunction of ion channels/transporters (ICTs) have been encountered in a variety of human tumors, including GC, and to play an important role in the processes of tumor cell proliferation, migration, invasion and apoptosis. Increasing evidence indicates that ICTs are at least partly involved in interactions between cancer cells and their hypoxic microenvironment. Here, we provide an overview of the different ICTs that regulate or are regulated by hypoxia in GC.

Conclusions And Perspectives: Hypoxia is one of the major obstacles to cancer therapy. Regulating cellular responses and factors under hypoxia can inhibit GC. Similarly, altering the expression or activity of ICTs, such as the application of ion channel inhibitors, can slow down the growth and/or migration of GC cells. Since targeting the hypoxic microenvironment and/or ICTs may be a promising strategy for the treatment of GC, more attention should be paid to the interplay between ICTs and the development and progression of GC in such a microenvironment.

Citing Articles

Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (Review).

Yun H, Dong F, Wei X, Yan X, Zhang R, Zhang X Oncol Rep. 2024; 53(1).

PMID: 39611496 PMC: 11622107. DOI: 10.3892/or.2024.8847.


Immune-related long noncoding RNA zinc finger protein 710-AS1-201 promotes the metastasis and invasion of gastric cancer cells.

Ding W, Chen W, Wang Y, Xu X, Wang Y, Yan Y World J Gastrointest Oncol. 2024; 16(2):458-474.

PMID: 38425400 PMC: 10900153. DOI: 10.4251/wjgo.v16.i2.458.


Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach.

Klug K, Spitzel M, Hans C, Klein A, Schottmann N, Erbacher C Int J Mol Sci. 2023; 24(20).

PMID: 37895103 PMC: 10607880. DOI: 10.3390/ijms242015422.


Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets.

Sanchez-Sandoval A, Hernandez-Plata E, Gomora J Front Pharmacol. 2023; 14:1206136.

PMID: 37456756 PMC: 10348687. DOI: 10.3389/fphar.2023.1206136.


ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity.

Dong F, Li H, Liu L, Yao L, Wang J, Xiang D Int J Biol Sci. 2023; 19(8):2613-2629.

PMID: 37215979 PMC: 10197896. DOI: 10.7150/ijbs.81498.


References
1.
Semenza G . Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012; 33(4):207-14. PMC: 3437546. DOI: 10.1016/j.tips.2012.01.005. View

2.
Jing G, Zhang M . Transient Receptor Potential Melastatin 2:an Ion Channel for Oxidative Stress Sensing. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016; 38(3):364-7. DOI: 10.3881/j.issn.1000-503X.2016.03.023. View

3.
Webb B, Chimenti M, Jacobson M, Barber D . Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011; 11(9):671-7. DOI: 10.1038/nrc3110. View

4.
Zhang S, Wang X, Yin Z, Zhao W, Zhou J, Zhao B . Chloride intracellular channel 1 is overexpression in hepatic tumor and correlates with a poor prognosis. APMIS. 2013; 121(11):1047-53. DOI: 10.1111/apm.12093. View

5.
Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View